Celleron Therapeutics Revenue
Biotechnology Research • 
Oxford, England, United Kingdom • 1-10 Employees
$
Celleron Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Celleron Therapeutics
Cj Coll
Operations Director
Company overview
| Headquarters | Magdalen Centre, Oxford Science Park, Robert Robinson Ave, Oxford, OX4 4GA, GB |
| Phone number | +447766255216 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Employees | 1-10 |
| Socials |
About Celleron Therapeutics
Celleron Therapeutics was a clinical-stage Oxford University spinout focussed on the clinical development of new drugs against unmet cancers. In late 2022, it merged with Argonaut Therapeutics to form IngenOx Therapeutics. Celleron’s Vision is to build a global pipeline of clinical products which are safe and effective in unmet indications, supported by a precision medicine platform.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
Celleron Therapeutics has never raised funding before.
United States
Canada
United Arab Emirates
Japan
Frequently asked questions
Celleron Therapeutics is located in Oxford, England, GB.
You can reach Celleron Therapeutics at +447766255216.
Celleron Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Celleron Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Celleron Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
